These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The underuse of digoxin in heart failure, and approaches to appropriate use. Ahmed A; Young JB; Gheorghiade M CMAJ; 2007 Feb; 176(5):641-3. PubMed ID: 17325329 [No Abstract] [Full Text] [Related]
3. Pharmacogenetics in heart failure: how it will shape the future. Hamad E; Feldman AM Heart Fail Clin; 2010 Jan; 6(1):1-10. PubMed ID: 19945055 [TBL] [Abstract][Full Text] [Related]
4. Sex-Based Differences in Hemodynamic Response to Inotropes: A Subanalysis of the DOREMI Trial. Roy R; Han J; Mathew R; Di Santo P; Hibbert B; Neyestanak M; Grinstein J; Belkin MN JACC Heart Fail; 2023 Sep; 11(9):1275-1277. PubMed ID: 37480883 [No Abstract] [Full Text] [Related]
5. Clinical pharmacokinetics of digoxin. Iisalo E Clin Pharmacokinet; 1977; 2(1):1-16. PubMed ID: 322907 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors. Williams KB; Larsson AT; Keller BJ; Chaney KE; Williams RL; Bhunia MM; Draper GM; Jubenville TA; Rathe SK; Moertel CL; Ratner N; Largaespada DA bioRxiv; 2024 Mar; ():. PubMed ID: 38585724 [TBL] [Abstract][Full Text] [Related]
7. Digoxin and Standard-of-Care Therapy for Heart Failure Patients with COVID-19: Analysis of Data from the US Military Health System (MHS) Data Repository. Banaag AL; Pollard HB; Koehlmoos TP Drugs Real World Outcomes; 2023 Jun; 10(2):299-307. PubMed ID: 36933173 [TBL] [Abstract][Full Text] [Related]
8. The Shared Ethical Responsibility of Medically and Non-medically Qualified Experts in Human Drug Development Teams. Kerpel-Fronius S; Becker S; Barrett J; Brun J; Carlesi R; Chan A; Collia LF; Dubois DJ; Kleist P; Koski G; Kurihara C; Laranjeira LF; Schenk J; Silva H Front Pharmacol; 2018; 9():843. PubMed ID: 30233356 [TBL] [Abstract][Full Text] [Related]
9. Case files of the medical toxicology fellowship of the California poison control system-San Francisco: calcium plus digoxin-more taboo than toxic? Erickson CP; Olson KR J Med Toxicol; 2008 Mar; 4(1):33-9. PubMed ID: 18338310 [TBL] [Abstract][Full Text] [Related]
10. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Ahmed A; Rich MW; Love TE; Lloyd-Jones DM; Aban IB; Colucci WS; Adams KF; Gheorghiade M Eur Heart J; 2006 Jan; 27(2):178-86. PubMed ID: 16339157 [TBL] [Abstract][Full Text] [Related]
11. Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction. Ahmed A; Aban IB; Weaver MT; Aronow WS; Fleg JL Eur J Heart Fail; 2006 Jun; 8(4):409-19. PubMed ID: 16311070 [TBL] [Abstract][Full Text] [Related]
13. [Digoxin and heart insufficiency. An old pharmaceutical with new future]. Kjeldsen KP; Nørgaard A Ugeskr Laeger; 1999 May; 161(22):3264. PubMed ID: 10485202 [No Abstract] [Full Text] [Related]
14. Digoxin for the treatment of heart failure. Hallberg P; Michaëlsson K; Melhus H N Engl J Med; 2003 Feb; 348(7):661-3; author reply 661-3. PubMed ID: 12587575 [No Abstract] [Full Text] [Related]
16. To dig or not to dig. Dagenais GR; Brophy JM Trans Am Clin Climatol Assoc; 1998; 109():51-61. PubMed ID: 9601127 [No Abstract] [Full Text] [Related]
17. Use of digoxin in heart failure. Should we bother? Frank J; Evans MF Can Fam Physician; 1997 Jul; 43():1227-8. PubMed ID: 9241459 [No Abstract] [Full Text] [Related]
18. Digoxin--new perspective on an old drug. Eichhorn EJ; Gheorghiade M N Engl J Med; 2002 Oct; 347(18):1394-5. PubMed ID: 12409540 [No Abstract] [Full Text] [Related]